Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2012 1
2013 1
2018 1
2019 1
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Fuentes-Saguar
Page 1
Clinicopathological associations and prognostic values of IDH1 gene mutation, MGMT gene promoter methylation, and PD-L1 expressions in high-grade glioma treated with standard treatment.
July J, Patricia D, Gunawan PY, Setiajaya H, Ginting TE, Putra TP, Wuisan Z, Budhiarko D, Masykura N, Prayogi G, Utomo AR, Tandean S, Loe ML. July J, et al. Among authors: patricia d. Pan Afr Med J. 2020 Aug 20;36:309. doi: 10.11604/pamj.2020.36.309.24831. eCollection 2020. Pan Afr Med J. 2020. PMID: 33282092 Free PMC article.
A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies.
de Jong J, Hellemans P, De Wilde S, Patricia D, Masterson T, Manikhas G, Myasnikov A, Osmanov D, Córdoba R, Panizo C, de Zwart L, Snoeys J, Chauhan V, Jiao J, Sukbuntherng J, Ouellet D. de Jong J, et al. Among authors: patricia d. Leuk Lymphoma. 2018 Dec;59(12):2888-2895. doi: 10.1080/10428194.2018.1460474. Epub 2018 May 30. Leuk Lymphoma. 2018. PMID: 29846137 Clinical Trial.
Chronological and morphological study of heart development in the rat.
Marcela SG, Cristina RM, Angel PG, Manuel AM, Sofía DC, Patricia de LR, Bladimir RR, Concepción SG. Marcela SG, et al. Among authors: patricia de lr. Anat Rec (Hoboken). 2012 Aug;295(8):1267-90. doi: 10.1002/ar.22508. Epub 2012 Jun 19. Anat Rec (Hoboken). 2012. PMID: 22715162 Free article.
Diagnosis and treatment of major depression 2007.
Patricia D, Price DW. Patricia D, et al. Perm J. 2007 Summer;11(3):35-42. doi: 10.7812/tpp/07-038. Perm J. 2007. PMID: 21461110 Free PMC article. No abstract available.
Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer.
Drake CG, Pachynski RK, Subudhi SK, McNeel DG, Antonarakis ES, Bauer TM, Lauer P, Brockstedt D, Patricia D, Wade M, Zudaire E, Bandyopadhyay N, Parasrampuria DA, Girgis S, Mason GE, Knoblauch RE, Stone N, Infante JR, Gottardis MM, Fong L. Drake CG, et al. Among authors: patricia d. Prostate Cancer Prostatic Dis. 2021 Jul 13. doi: 10.1038/s41391-021-00402-8. Online ahead of print. Prostate Cancer Prostatic Dis. 2021. PMID: 34257408
A phase I trial to determine the safety, pharmacokinetics, and pharmacodynamics of intercalated BMS-690514 with paclitaxel/carboplatin (PC) in advanced or metastatic solid malignancies.
Chow LQ, Jonker DI, Dy GK, Nicholas G, Fortin C, Patricia D, Adjei AA, Belani CP, Gupta A, Park JS, Zhang S, Sbar EI, Laurie SA. Chow LQ, et al. Among authors: patricia d. Cancer Chemother Pharmacol. 2013 May;71(5):1273-85. doi: 10.1007/s00280-013-2126-9. Epub 2013 Mar 7. Cancer Chemother Pharmacol. 2013. PMID: 23468081 Clinical Trial.